Chemoinformaics analysis of Glucodigitoxigenin
| Molecular Weight | 536.662 | nRot | 4 |
| Heavy Atom Molecular Weight | 492.31 | nRig | 31 |
| Exact Molecular Weight | 536.299 | nRing | 6 |
| Solubility: LogS | -3.177 | nHRing | 2 |
| Solubility: LogP | 1.838 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 29 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 84.9869 |
| nHD | 5 | BPOL | 50.2171 |
| QED | 0.319 |
| Synth | 5.148 |
| Natural Product Likeliness | 2.586 |
| NR-PPAR-gamma | 0.255 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.027 |
| HIA | 0.935 |
| CACO-2 | -5.436 |
| MDCK | 0.0000379 |
| BBB | 0.23 |
| PPB | 0.950564 |
| VDSS | 1.118 |
| FU | 0.0474818 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.335 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.373 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.532 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.34 |
| CYP3a4-inh | 0.028 |
| CYP3a4-sub | 0.086 |
| CL | 4.995 |
| T12 | 0.112 |
| hERG | 0.083 |
| Ames | 0.064 |
| ROA | 0.964 |
| SkinSen | 0.07 |
| Carcinogencity | 0.066 |
| EI | 0.005 |
| Respiratory | 0.917 |
| NR-Aromatase | 0.834 |
| Antiviral | Yes |
| Prediction | 0.708379 |